Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Modeling cell-cell interactions to advance drug discovery in Idiopathic Pulmonary Fibrosis.
bioRxiv : the preprint server for biology·2026
Same author
Bidirectional fibrogenic cross-talk revealed in a human iPSC-derived epithelial-mesenchymal co-culture model of pulmonary fibrosis.
bioRxiv : the preprint server for biology·2026
Same author
MI-181 enhances ciliation and cilia length in a cigarette smoke exposed airway epithelial model.
Scientific reports·2026
Related Experiment Video
Updated: Jul 8, 2026
09:47
Isolation of CD146+ Resident Lung Mesenchymal Stromal Cells from Rat Lungs
Published on: June 17, 2016
Stem cells and chronic lung disease.
Brigitte N Gomperts1, Robert M Strieter
1Mattel Children's Hospital, Department of Pediatrics, Division of Pediatric Hematology, Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA. bgomperts@mednet.ucla.edu
Annual Review of Medicine
|August 5, 2006
Summary
Stem cells aid lung repair by regenerating airway epithelium. The lung stem cell niche influences repair outcomes, potentially leading to fibrosis if aberrant.
Area of Science:
- Pulmonary Medicine
- Regenerative Medicine
- Stem Cell Biology
Background:
- Lung injury triggers stem cell responses for repair.
- Stem cells reside in lung niches or mobilize from bone marrow.
- Aberrant repair involving stem cells can cause lung fibrosis.
Purpose of the Study:
- To review current knowledge on stem cells in lung repair and regeneration.
- To identify gaps in understanding stem cell roles in lung injury.
- To explore the influence of the stem cell niche on repair outcomes.
Main Methods:
- Literature review of stem cell biology in lung injury.
- Analysis of stem cell mobilization and recruitment mechanisms.
- Examination of stem cell niche interactions in lung regeneration.
Main Results:
- Stem cells are crucial for normal airway epithelial regeneration.
- The lung stem cell niche critically determines repair pathways (regenerative vs. fibrotic).
- Mobilized stem cells from circulation can contribute to severe lung injury repair.
Conclusions:
- Harnessing stem cells offers potential for lung repair and regeneration.
- Understanding the stem cell niche is key to directing lung repair.
- Further research is needed to elucidate complex stem cell-mediated lung repair processes.